Chong Kun Dang makes antidiabetic ‘Duvimet XR Tab’ smaller

Published: 2018-01-04 16:26:00
Updated: 2018-01-04 14:44:50

Chong Kun Dang(CEO Young-Joo Kim) announced on the 3rd that the company has launched a new product with enhanced convenience by downsizing ‘Duvimet XR Tab,’ a combination drug for the treatment of diabetes.

Duvimet XR Tab is an incrementally modified drug improvement in antidiabetic efficacy and...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.